1. Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. Issue 1 (1st January 2015) Authors: Knuf, Markus; Leroux-Roels, Geert; Rümke, Hans. C.; Abarca, Katia; Rivera, Luis; Lattanzi, Maria; Pedotti, Paola; Arora, Ashwani; Kieninger-Baum, Dorothee; Della Cioppa, Giovanni Journal: Vaccine Issue: Volume 33:Issue 1(2015) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. Issue 1 (1st January 2015) Authors: Knuf, Markus; Leroux-Roels, Geert; Rümke, Hans. C.; Abarca, Katia; Rivera, Luis; Lattanzi, Maria; Pedotti, Paola; Arora, Ashwani; Kieninger-Baum, Dorothee; Della Cioppa, Giovanni Journal: Vaccine Issue: Volume 33:Issue 1(2015) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗